Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis

Hee-Young Yoon, Sun-Young Kim, Ok-Jin Kim, Jin Woo Song

Source: Eur Respir J, 57 (5) 2001877; 10.1183/13993003.01877-2020
Journal Issue: May

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Abstract

Ambient air pollution is associated with the prognosis of idiopathic pulmonary fibrosis (IPF) patients. We aimed to identify the impacts of individual exposure to particulate matter with a 50% cut-off aerodynamic diameter of 10 µm (PM10) and nitrogen dioxide (NO2) on IPF patients' mortality.

1114 patients (mean age 65.7 years; male 80.5%) diagnosed with IPF between 1995 and 2016 were included in this study. Individual-level long-term concentrations of PM10 and NO2 at residential addresses of patients were estimated using a national-scale exposure prediction model. The effect of PM10 and NO2 on mortality was estimated using a Cox proportional hazards model adjusted for individual- and area-level covariates.

The median follow-up period was 3.8 years and 69.5% of the patients died or underwent lung transplantation. When adjusted for individual- and area-level covariates, a 10 ppb increase in NO2 concentration was associated with a 17% increase in mortality (hazard ratio (HR) 1.172, 95% CI 1.030–1.344; p=0.016). When IPF patients were stratified by age (=65 versus <65 years) or by sex, NO2 was a significant prognostic factor for mortality in the elderly (HR 1.331, 95% CI 1.010–1.598; p=0.010). When stratified by age and sex jointly, NO2 showed the stronger association with mortality in elderly males (HR 1.305, 95% CI 1.072–1.598; p=0.008) than in other groups. PM10 was not associated with IPF mortality in all patients and in subgroups stratified by age or sex.

Our findings suggest that increased exposure to NO2 can increase the risk of mortality in patients with IPF, specifically in elderly males.



Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hee-Young Yoon, Sun-Young Kim, Ok-Jin Kim, Jin Woo Song. Nitrogen dioxide increases the risk of mortality in idiopathic pulmonary fibrosis. Eur Respir J, 57 (5) 2001877; 10.1183/13993003.01877-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diffusing capacity for carbon monoxide and mortality in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Diffusing capacity for carbon monoxide (DLco) may predict appearance of pulmonary hypertension in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib
Source: International Congress 2016 – IPF treatment II
Year: 2016



Slope of exercise ventilation to carbon dioxide production in patients with pulmonary arterial hypertension, either primary or associated with connective tissue disease
Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange
Year: 2008

Association between exposure to air pollution and mortality in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia
Year: 2019

Is chronic exposure to air pollutants a risk factor for the development of idiopathic pulmonary fibrosis?
Source: Eur Respir J, 51 (1) 1702663; 10.1183/13993003.02663-2017
Year: 2018



Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
Source: Eur Respir J 2014; 43: 1124-1131
Year: 2014



Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012



Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2012; 39: 125-132
Year: 2012



Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2011; 39: 125-132
Year: 2012



Exercise-induced pulmonary hypertension in patients with idiopathic pulmonary fibrosis: effects of oxygen
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007

A prothrombotic state is associated with increased mortality in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013

Ventilatory inefficiency relative to oxygen uptake and carbon dioxide output are independent predictors of mortality in pulmonary arterial hypertension
Source: Annual Congress 2013 –Respiratory physiology in health and disease
Year: 2013

Noninvasive positive pressure ventilation using helium:oxygen versus air:oxygen in acute respiratory failure in chronic obstructive pulmonary disease patients exposed to sulfur mustard
Source: Annual Congress 2008 - Use of noninvasive ventilation in various conditions
Year: 2008


Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 40: 93-100
Year: 2012



PaO2/FiO2 with low PEEP using NPPV is a significant predictor on survival in acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015



Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Carbon monoxide diffusing capacity (DLCO) in COVID-19 survivors versus idiopathic pulmonary fibrosis (IPF): the pathogenetic features
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021


Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019